Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 6, 2002 - Issue 3
Submit an article Journal homepage
31
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Quetiapine in tardive dyskinesia

Suresh Chari
,
Ak Jainer
,
Andrew Ashley-Smith
&
Maxine Cleaver
Pages 175-177 | Published online: 12 Jul 2009

  • Uhrbrand L, Faurbye A (1960) Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine and ECT. Psychopharmacologia 1: 408-18.
  • Bazire S (2000) Psychotropk Drug Directory 2000: A professionals' pocket handbook and aide memoire. Mark Allen Publishing, Dinton, 82.
  • Jeste DV, Caliguri MP, Paulen JS et al (1993) Tardive dyskinesia. Schizophrenia Bull 19: 305-15.
  • Jeste DV, Caliguri MP, Paulen JS et al (1995) Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients. Arch Gen Psychiatry 52: 756-65.
  • American Psychiatric Association (1992) Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. APA, Washington, DC.
  • van Harten PN, Hoek HW Matroos GE et al (1998) Intermittent neuroleptic treatment and risk for tardive dyskinesia: The Curacao extrapyramidal syndrome study. III. Am J Psychiatry 155: 565-7.
  • Carlsson A (1970) Biochemical implications of dopa-induced actions on the central nervous system with particular reference to abnormal movements. In: L-Dopa and Parkinsonism (eds A Barbeau & FH McDowell). Davis, Philadelphia.
  • Guy W (1976) Assessment Manual for Psychopharmacology (revised). Washington DC: Department of Health, Education, and Welfare. Early Clinical Drug Evaluation Unit
  • Lieberman JA, Saltz BL, Johns CA et al (1991) The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158: 503-10.
  • Farah A (2001) Reduction of tardive dyskinesia with quetiapine. Schizophrenia Res 47: 309-10.
  • Vesely C, Kufferle B, Brucke T et al (2000) Remission of severe tardive dyskinesia in a schizophrenic patient treated with the atypical antipsychotic substance quetiapine. Int Gin Psychopharmacol 15: 57-60.
  • Almeida OP (1998) Olanzapine for the treatment of tardive dyskinesia. J Clin Psychiatry 59: 380-1.
  • O'Brien J, Barber R (1998) Marked improvement in tardive dyskinesia following treatment with olanzapine in an elderly subject Br J Psychiatry 172: 186-9.
  • Rangwani SR, Gupta S, Burke WJ et al (1996) Improvement of debilitating tardive dyskinesia with risperidone. Ann Clin Psychiatry 8: 27-9.
  • Kooptiwoot S, Settachan T (2000) Improvement of tardive dyskinesia with risperidone. A case report J Med Assoc Thailand 83: 1430-2.
  • Morgenstern H, Glazer WM (1993) Identifying risk factors for tardive dyskinesia among long term outpatients maintained with neuroleptic medications. Results of the Yale tardive dyskinesia study. Arch Gen Psychiatry 50: 723-33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.